Greater Suppression of Glucagon, Lipolysis, and Ketogenesis with Insulin Glargine U300 as Compared with Glargine U100 in Type 1 Diabetes Mellitus.


Journal

Diabetes technology & therapeutics
ISSN: 1557-8593
Titre abrégé: Diabetes Technol Ther
Pays: United States
ID NLM: 100889084

Informations de publication

Date de publication:
01 2020
Historique:
pubmed: 15 8 2019
medline: 6 11 2020
entrez: 15 8 2019
Statut: ppublish

Résumé

The aim of this study was to establish the effects of clinical doses of Gla-300 versus Gla-100 on suppression of glucagon, lipolysis, and ketogenesis in type 1 diabetes mellitus (T1DM). Eighteen persons with T1DM (age 40 ± 12 years, diabetes duration 26 ± 12 years, body mass index 23.4 ± 2 kg/m

Identifiants

pubmed: 31411498
doi: 10.1089/dia.2019.0231
doi:

Substances chimiques

Hypoglycemic Agents 0
Insulin Glargine 2ZM8CX04RZ
Glucagon 9007-92-5

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

57-61

Auteurs

Paola Lucidi (P)

Section of Endocrinology & Metabolism, Department of Medicine, Perugia University School of Medicine, Perugia, Italy.

Francesca Porcellati (F)

Section of Endocrinology & Metabolism, Department of Medicine, Perugia University School of Medicine, Perugia, Italy.

Patrizia Cioli (P)

Section of Endocrinology & Metabolism, Department of Medicine, Perugia University School of Medicine, Perugia, Italy.

Paola Candeloro (P)

Section of Endocrinology & Metabolism, Department of Medicine, Perugia University School of Medicine, Perugia, Italy.

Anna Marinelli Andreoli (A)

Section of Endocrinology & Metabolism, Department of Medicine, Perugia University School of Medicine, Perugia, Italy.

Geremia B Bolli (GB)

Section of Endocrinology & Metabolism, Department of Medicine, Perugia University School of Medicine, Perugia, Italy.

Carmine G Fanelli (CG)

Section of Endocrinology & Metabolism, Department of Medicine, Perugia University School of Medicine, Perugia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH